female breast cancer

Showing 1 - 23 of 23

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Lymphedema, Lymphedema Arm, Lymphedema of Upper Arm Trial in United States (procedure, diagnostic test, other)

Recruiting
  • Lymphedema
  • +5 more
  • Immediate Lymphatic Reconstruction
  • +4 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 16, 2023

Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant

Not yet recruiting
  • Breast Cancer
  • +5 more
  • Breast Surgery (BCS or mastectomy) with TAD/SNB
  • Adjuvant Radiation Therapy
  • (no location specified)
Oct 24, 2023

Female Breast Cancer Trial in Germany

Recruiting
  • Female Breast Cancer
    • Moenchengladbach, NRW, Germany
    • +4 more
    Mar 30, 2023

    Female Breast Cancer Trial in Sohag (Hormonal Antineoplastics, Chemotherapy drug)

    Not yet recruiting
    • Female Breast Cancer
    • Hormonal Antineoplastics
    • Chemotherapy drug
    • Sohag, Egypt
      amal Ali
    Feb 23, 2023

    Ultra-hypofractionated Radiotherapy in Breast Cancer Patients

    Recruiting
    • Female Breast Cancer
    • ultra-hypofractionated whole breast irradiation
    • Perugia, Italy
      Radiation Oncology Section, Department of Medicine and Surgery,
    Oct 16, 2022

    Female Breast Cancer Trial in Luzhou (Acupuncture)

    Terminated
    • Female Breast Cancer
    • Acupuncture
    • Luzhou, China
      Xianliang Liu
    Aug 22, 2022

    Advanced Breast Cancer, Female Breast Cancer Trial in Beijing (FCN-437c, Letrozole or anastrozole, Goserelin acetate, Placebo,

    Recruiting
    • Advanced Breast Cancer
    • Female Breast Cancer
    • FCN-437c, Letrozole or anastrozole, Goserelin acetate
    • Placebo, Letrozole or anastrozole, Goserelin acetate
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Jul 4, 2022

    Advanced Breast Cancer, Female Breast Cancer Trial in Shanghai (FCN-437c,Fulvestrant,Goserelin acetate,

    Recruiting
    • Advanced Breast Cancer
    • Female Breast Cancer
    • FCN-437c,Fulvestrant,Goserelin acetate
    • Placebo,Fulvestrant,Goserelin acetate
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 30, 2022

    Female Breast Cancer, Depression, Pain Trial in Nicosia (Acceptance and Commitment Therapy, Waitlist Control Group)

    Recruiting
    • Female Breast Cancer
    • +2 more
    • Acceptance and Commitment Therapy
    • Waitlist Control Group
    • Nicosia, Non-US/Non-Canadian, Cyprus
      University of Cyprus
    May 12, 2022

    Female Breast Cancer Trial in Birmingham (Home-based exercise intervention)

    Recruiting
    • Female Breast Cancer
    • Home-based exercise intervention
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Oct 13, 2021

    Surgery, 75 Years Old and More, Female Breast Cancer Trial in France (Medical consultation for a Standardized Geriatric

    Active, not recruiting
    • Surgery
    • +2 more
    • Medical consultation for a Standardized Geriatric Evaluation
    • Angouleme, France
    • +5 more
    Sep 28, 2021

    Tomosymthesis for Breast Mass Lesion Characterization

    Not yet recruiting
    • Female Breast Cancer
      • (no location specified)
      Apr 24, 2021

      Female Breast Cancer, Fatigue, Quality of Life Trial in Meldola (Yoga lessons)

      Active, not recruiting
      • Female Breast Cancer
      • +4 more
      • Yoga lessons
      • Meldola, Forlì-Cesena, Italy
        IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"
      Feb 25, 2021

      Female Breast Cancer Trial in Madison (Estradiol)

      Terminated
      • Female Breast Cancer
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Nov 19, 2019

      Female Breast Cancer Trial in Madison (docetaxel + cyclophosphamide + pegfilgrastim)

      Completed
      • Female Breast Cancer
      • docetaxel + cyclophosphamide + pegfilgrastim
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Nov 14, 2019

      Female Breast Cancer, Male Breast Cancer Trial (Bilateral mastectomy, Biopsy)

      Unknown status
      • Female Breast Cancer
      • Male Breast Cancer
      • Bilateral mastectomy
      • Biopsy
      • (no location specified)
      Nov 24, 2017

      Female Breast Cancer Trial in Hamburg (Side effect prevention training (SEPT), Attention Control group (ACG))

      Unknown status
      • Female Breast Cancer
      • Side effect prevention training (SEPT)
      • Attention Control group (ACG)
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Sep 24, 2017

      Endocrine Therapy in Women With Breast Cancer

      Unknown status
      • Female Breast Cancer
      • Enhanced information about endocrine therapy
      • Marburg, Hessen, Germany
        Philipps University Marburg Medical Center
      Sep 24, 2017

      Female Sexual Dysfunction in Breast Cancer Patients

      Unknown status
      • Female Breast Cancer
        • (no location specified)
        May 13, 2017

        Female Breast Cancer Trial in Mumbai (2,6-Diisopropylphenol, Fluoromethyl hexafluoroisopropyl ether, Fentanyl Citrate)

        Unknown status
        • Female Breast Cancer
        • Mumbai, Maharashtra, India
          Tata Memorial Centre
        Jan 12, 2017

        Female Breast Cancer Trial in Beijing (Toremifene; Anastrozole)

        Unknown status
        • Female Breast Cancer
        • Toremifene; Anastrozole
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Nov 30, 2016

        Breast Cancer in Young Women: Is it Different?

        Suspended
        • Female Breast Cancer
          • Riyadh, Saudi Arabia
            King Abdul Aziz Medical City for National Guard Health Affairs
          May 12, 2016